AdvertisementAdvertise with NZME.
Latest FromBiotechnology
Kiwi drug treatment ready for the big stage
A drug co-invented by a University of Auckland researcher and part funded by a New Zealand venture capital company is about to take the next step on the path to gaining a foothold in the global 'wound-healing' market.
Receivers called to Botry-Zen
Botry-Zen Ltd has asked its banker, Bank of New Zealand, to appoint receivers.
Bio-tech firm sees chance for fruitful float
Hamilton-based bio-technology company BioVittoria is hoping investors will see a sweet opportunity in its sharemarket float.